126301-16-4

Basic information

• Product Name: (S)-Methanesulphonic acid 2-Boc-aminopropyl ester
• Synonyms: (S)-Methanesulphonic acid 2-Boc-aminopropyl ester;(S)-2-(tert-butoxycarbonylaMino)propyl Methanesulfonate;(S)-Methanesulfonic acid 2-Boc-amino-propyl ester
• CAS NO: 126301-16-4
• Molecular Formula: C₉H₁₉NO₅S
• Molecular Weight: 253
• Mol File: 126301-16-4.mol
• Article Data: 75

Chemical Properties

• Boiling Point: 397.918°C at 760 mmHg
• Flash Point: 194.454°C
• Appearance: /
• Density: 1.166g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.462
• CAS DataBase Reference: (S)-Methanesulphonic acid 2-Boc-aminopropyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-Methanesulphonic acid 2-Boc-aminopropyl ester(126301-16-4)
• EPA Substance Registry System: (S)-Methanesulphonic acid 2-Boc-aminopropyl ester(126301-16-4)

Safety Data

• Hazardous Substances Data: 126301-16-4(Hazardous Substances Data)

Usage

General Description

(S)-Methanesulphonic acid 2-Boc-aminopropyl ester is a chemical compound that is commonly used in organic synthesis. It is a derivative of (S)-Methanesulphonic acid, a strong acid commonly used as a catalyst in various chemical reactions. The 2-Boc-aminopropyl ester moiety makes this compound a useful reagent for the protection of amine groups in organic synthesis, as the Boc group can be easily removed under mild conditions, allowing for further functionalization of the amine group. (S)-Methanesulphonic acid 2-Boc-aminopropyl ester is often employed in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals due to its versatility and stability.

InChI:InChI=1/C9H19NO5S/c1-7(6-14-16(5,12)13)10-8(11)15-9(2,3)4/h7H,6H2,1-5H3,(H,10,11)/t7-/m0/s1

Upstream product

• 2749-11-3 (S)-Alaninol 
• 124-63-0 methanesulfonyl chloride 
• 79069-13-9 (S)-2-t-butoxycarbonylaminopropan-1-ol 
• 109208-68-6 Boc-Ala-O-COO-isoBu 
• 15761-38-3 L-N-Boc-Ala 
• 28875-17-4 (S)-N-(tert-butoxycarbonyl)alanine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 3744-87-4 Boc-(R)-Ala 
• 129991-09-9 (R)-N-Boc-2-aminobutane 
• 79069-13-9 (R)-2-tertbutoxycarbonylamino-1-propanol 
• 91103-47-8 N-(tert-butoxycarbonyl)-D-alanine methyl ester 

Downstream Products

• 197020-60-3 (S)-tert-butyl 2-methylaziridine-1-carboxylate 
• 170367-69-8 (3-amino-1(R)-methylpropyl)carbamic acid, 1,1-dimethylethyl ester 
• 170367-70-1 [1(R)-methyl-3-[(phenylmethyl)amino]propyl]carbamic acid, 1,1-dimethylethyl ester 
• 170367-71-2 3-[(3-cyanopropyl)(phenylmethyl)amino-1(R)-methylpropyl]carbamic acid, 1,1-dimethylethyl ester 
• 170367-72-3 3-[(4-aminobutyl)(phenylmethyl)amino-1(R)-methylpropyl]carbamic acid, 1,1-dimethylethyl ester 
• 252353-69-8 [3-[[4-(2,4-dioxo-3-oxazolidinyl)butyl](phynylmethyl)amino]-1-methylpropyl]carbamic acid, 1,1-dimethylethyl ester (R) 
• 170367-76-7 2,2,6-trimethyl-4,15-dioxo-9-(phenylmethyl)-3,16-dioxa-5,9,14-triazaoxadecan-18-oic acid (R) 
• 170367-82-5 [21-[[(1,1-dimethylethoxy)carbonyl]amino]-1,25,25-trimethyl-10,12,23-trioxo-4-(phenylmethyl)-24-oxa-4,9,13,20,22-pentaaza-21-hexacosen-1-yl]carbamic acid, 1,1-dimethylethyl ester (R) 
• 170367-78-9 [4-[[3-[[(1,1-dimethylethoxy)carbonyl]amino]butyl](phenylmethyl)amino]butyl]carbamic acid, 11-[[(1,1-dimethylethoxy)carbonyl]amino]-15,15-dimethyl-2,13-dioxo-14-oxa-3,4,12-triaza-11-hexadecen-1-yl ester (R) 
• 100927-10-4 tert-butyl N-[(1R)-2-amino-1-methyl-ethyl]carbamate 
• 129319-91-1 (R)-(-)-N-(tert-Butoxycarbonyl)-2-methylaziridine 

Relevant articles and documents

Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease

Using an iterative structure-activity relationship driven approach, we identified a CNS-penetrant 5-(trifluoromethyl)-1,2,4-oxadiazole (TFMO, 12) with a pharmacokinetic profile suitable for probing class IIa histone deacetylase (HDAC) inhibition in vivo.

HETEROCYCLIC COMPOUNDS

Provided herein are compounds of formula (I) which comprise a thiomorpholine 1,1-dioxide or 1-imino-thiomorpholine 1-oxide moiety, or pharmaceutically acceptable salts of any of the foregoing, pharmaceutical compositions that include a compound described herein (including salts of the compound) and methods of synthesizing the same. Also provided are methods of treating Hepatitis B viral (HBV) infections using a compound of formula (I), or pharmaceutically acceptable salts thereof.

SULFUR-CONTAINING POLYCYCLIC-HYDROXYPYRIDONE CARBOXAMIDE ANALOG AGAINST HIV

The disclosure discloses a sulfur-containing polycyclic-hydroxypyridone carboxamide analog against HIV and an application thereof. The sulfur-containing polycyclic-hydroxypyridone carboxamide analog has a compound represented by the following formula (I)